Skip to content
10-Q

Quarterly Report

MEDICINES CO /DE

0001113481-19-000029

← back to feed
Filed
Oct 30, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Oct 28, 2019 79.72M sh
Shares Diluted Q3 2019 · Sep 30, 2019 80.13M sh
Shares Diluted Q3 2019 · Sep 30, 2019 75.93M sh
Shares Diluted Q3 2019 · Sep 30, 2018 73.54M sh
Shares Diluted Q3 2019 · Sep 30, 2018 73.56M sh
Capex Q3 2019 · Sep 30, 2019 $0
Capex Q3 2019 · Sep 30, 2018 $7K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$159.31M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$222.77M
Short Term Investments Q3 2019 · Sep 30, 2019 $2.53M
Short Term Investments Q3 2019 · Dec 31, 2018 $2.63M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $265.85M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $238.31M
Cash And Equivalents Q3 2019 · Sep 30, 2018 $118.71M
Stockholders Equity Q3 2019 · Sep 30, 2019 −$59.54M
Stockholders Equity Q3 2019 · Jun 30, 2019 $38.13M
Stockholders Equity Q3 2019 · Mar 31, 2019 −$75.39M
Stockholders Equity Q3 2019 · Dec 31, 2018 −$22.26M
Stockholders Equity Q3 2019 · Sep 30, 2018 −$26.56M
Stockholders Equity Q3 2019 · Jun 30, 2018 $21.23M
Stockholders Equity Q3 2019 · Mar 31, 2018 $67.66M
Stockholders Equity Q3 2019 · Dec 31, 2017 $24.91M
Current Liabilities Q3 2019 · Sep 30, 2019 $423.14M
Current Liabilities Q3 2019 · Dec 31, 2018 $58.41M
Total Liabilities Q3 2019 · Sep 30, 2019 $923.27M
Total Liabilities Q3 2019 · Dec 31, 2018 $863.95M
Current Assets Q3 2019 · Sep 30, 2019 $326.73M
Current Assets Q3 2019 · Dec 31, 2018 $294.8M
Total Assets Q3 2019 · Sep 30, 2019 $897.27M
Total Assets Q3 2019 · Dec 31, 2018 $841.69M
Eps Diluted Q3 2019 · Sep 30, 2019 −$0.92
Eps Diluted Q3 2019 · Sep 30, 2019 −$2.55
Eps Diluted Q3 2019 · Sep 30, 2018 −$0.75
Eps Diluted Q3 2019 · Sep 30, 2018 −$1.10
Eps Basic Q3 2019 · Sep 30, 2019 −$0.92
Eps Basic Q3 2019 · Sep 30, 2019 −$2.55
Eps Basic Q3 2019 · Sep 30, 2018 −$0.75
Eps Basic Q3 2019 · Sep 30, 2018 −$1.10
Sga Expense Q3 2019 · Sep 30, 2019 $18.6M
Sga Expense Q3 2019 · Sep 30, 2019 $55.47M
Sga Expense Q3 2019 · Sep 30, 2018 $6.83M
Sga Expense Q3 2019 · Sep 30, 2018 $56.79M
Rd Expense Q3 2019 · Sep 30, 2019 $42.77M
Rd Expense Q3 2019 · Sep 30, 2019 $97.89M
Rd Expense Q3 2019 · Sep 30, 2018 $32.74M
Rd Expense Q3 2019 · Sep 30, 2018 $103.4M
Net Income Q3 2019 · Sep 30, 2019 −$73.99M
Net Income Q3 2019 · Sep 30, 2019 −$193.91M
Net Income Q3 2019 · Jun 30, 2019 −$60.06M
Net Income Q3 2019 · Mar 31, 2019 −$59.87M
Net Income Q3 2019 · Sep 30, 2018 −$55.63M
Net Income Q3 2019 · Sep 30, 2018 −$80.68M
Net Income Q3 2019 · Jun 30, 2018 −$54.2M
Net Income Q3 2019 · Mar 31, 2018 $29.15M
Operating Income Q3 2019 · Sep 30, 2019 −$61.37M
Operating Income Q3 2019 · Sep 30, 2019 −$153.36M
Operating Income Q3 2019 · Sep 30, 2018 −$48.83M
Operating Income Q3 2019 · Sep 30, 2018 −$165.68M
Cost Of Revenue Q3 2019 · Sep 30, 2019 $0
Cost Of Revenue Q3 2019 · Sep 30, 2019 $0
Cost Of Revenue Q3 2019 · Sep 30, 2018 $890K
Cost Of Revenue Q3 2019 · Sep 30, 2018 $6.56M
Revenue Q3 2019 · Sep 30, 2019 $0
Revenue Q3 2019 · Sep 30, 2019 $0
Revenue Q3 2019 · Sep 30, 2018 −$3.3M
Revenue Q3 2019 · Sep 30, 2018 $6.14M